APA (7th ed.) Citation

Chinta, S. J., Rajagopalan, S., Ganesan, A., & Andersen, J. K. A Possible Novel Anti-Inflammatory Mechanism for the Pharmacological Prolyl Hydroxylase Inhibitor 3,4-Dihydroxybenzoate: Implications for Use as a Therapeutic for Parkinson’s Disease. Wiley.

Chicago Style (17th ed.) Citation

Chinta, Shankar J., Subramanian Rajagopalan, Abirami Ganesan, and Julie K. Andersen. A Possible Novel Anti-Inflammatory Mechanism for the Pharmacological Prolyl Hydroxylase Inhibitor 3,4-Dihydroxybenzoate: Implications for Use as a Therapeutic for Parkinson’s Disease. Wiley.

MLA (9th ed.) Citation

Chinta, Shankar J., et al. A Possible Novel Anti-Inflammatory Mechanism for the Pharmacological Prolyl Hydroxylase Inhibitor 3,4-Dihydroxybenzoate: Implications for Use as a Therapeutic for Parkinson’s Disease. Wiley.